Hao Xiaoyan, Wang Zhiyun, Feng Yanmei, Li Mengjie, Hao Chenwei, Liang Yuanyuan, Zuo Chunyan, Yang Xuhong, Ma Dongrui, Wang YangYang, Li Shuangjie, Qi Shasha, Sun Yuemeng, Mao Chengyuan, Sun Shilei, Xu Yuming, Shi Changhe
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
NPJ Parkinsons Dis. 2025 Aug 21;11(1):252. doi: 10.1038/s41531-025-01104-x.
In this prospective cohort study, we analysed data from 502,364 participants (ages 40-69) in the UK Biobank, with follow-up until 2024. Logistic and Cox regression analysis identified generalized anxiety disorder (GAD) and obsessive-compulsive disorder (OCD) as independent risk factors for Parkinson's disease (PD), with post-traumatic stress disorder (PTSD) patients under 71 also at increased risk. Panic disorder (PAD) showed no association with PD. Further analysis of anxiolytic drug use revealed that selective serotonin reuptake inhibitors (SSRIs), benzodiazepines (BDZs), medium-to-high frequency use of tricyclic antidepressants (TCAs) and serotonin norepinephrine reuptake inhibitors (SNRIs) were linked to PD incidence, while low-frequency use of TCAs and SNRIs was not. Mediation analysis indicated that GAD influenced PD risk through the thalamus, brainstem, and left putamen, while OCD and PTSD affected PD risk via brain regions including the angular gyrus, thalamus, and postcentral gyrus. These findings provide novel insights into PD mechanisms and potential therapeutic targets.
在这项前瞻性队列研究中,我们分析了英国生物银行中502364名参与者(年龄在40至69岁之间)的数据,随访至2024年。逻辑回归和Cox回归分析确定广泛性焦虑障碍(GAD)和强迫症(OCD)是帕金森病(PD)的独立危险因素,71岁以下的创伤后应激障碍(PTSD)患者风险也增加。惊恐障碍(PAD)与PD无关联。对抗焦虑药物使用的进一步分析表明,选择性5-羟色胺再摄取抑制剂(SSRI)、苯二氮䓬类药物(BDZ)、中高频使用三环类抗抑郁药(TCA)和5-羟色胺去甲肾上腺素再摄取抑制剂(SNRI)与PD发病率相关,而低频使用TCA和SNRI则不然。中介分析表明,GAD通过丘脑、脑干和左侧壳核影响PD风险,而OCD和PTSD通过包括角回、丘脑和中央后回在内的脑区影响PD风险。这些发现为PD机制和潜在治疗靶点提供了新见解。